An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer

An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer

Abstract Triple‐negative breast cancer (TNBC) exhibits resistance to conventional treatments due to the presence of cancer stem cells (CSCs), causing postsurgical relapse and a dismal prognosis. Umbilical cord blood natural killer (UCB‐NK) cell‐based immunotherapy represents a promising strategy for...

Full description

Bibliographic Details
Main Authors: Yihang Gong, Wenjie Chen, Xiuxing Chen, Yizhan He, Hua Jiang, Xijian Zhang, Lijie Pan, Beibei Ni, Fan Yang, Yan Xu, Qi Zhang, Lei Zhou, Yusheng Cheng
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Advanced Science
Subjects:
hydrogel
sustained drug release
TNBC
UCB‐NK cell therapy
wound healing
Online Access:https://doi.org/10.1002/advs.202201271

Internet

https://doi.org/10.1002/advs.202201271

Similar Items